Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06979375 |
| Consolidated Lead Sponsor | Novo Nordisk |
| Therapeutic Condition Cohort | Cardiovascular and Thrombosis |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 200 participants (ESTIMATED) |
| Registered Start Date | 2025-06-30 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Flinders Medical Centre | Bedford Park, Australia | Open Hospital Dossier -> |
| Royal Hobart Hospital | Hobart, Australia | Open Hospital Dossier -> |
| Vseobecna fakultni nemocnice v Praze | Prague, Czechia | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Novo Nordisk across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.